Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis

scientific article published on June 2016

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.3350/CMH.2015.0040
P8608Fatcat IDrelease_rxjhkl4pzzabdikz3sagmqtkni
P932PMC publication ID4946399
P698PubMed publication ID27246353

P2093author name stringSang Hyun Kim
Yeon Seok Seo
Ho Sang Ryu
Soon Ho Um
Han Ah Lee
Seung Woon Park
Sun Young Yim
Yura Sim
P2860cites workAutoimmune hepatitis--Update 2015Q28081791
Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQ28248157
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisQ33784003
Diagnosis and management of autoimmune hepatitisQ34118165
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapyQ34286525
Clinical pharmacology and pharmacogenetics of thiopurinesQ34782066
Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational studyQ34825783
Treatment strategies in autoimmune hepatitisQ34936764
Current and future treatments of autoimmune hepatitisQ37503380
Autoimmune hepatitis: a comprehensive reviewQ38065506
Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymesQ41081740
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis.Q43244249
Mycophenolate mofetil as second line therapy in autoimmune hepatitis?Q46317682
Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.Q53160616
Thiopurine Methyltransferase in Humans: Development and Tissue DistributionQ67885458
Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survivalQ72122015
[Liver, blood proteins and food proteins]Q73958348
Lupoid hepatitisQ74334969
Safety issues in the management of autoimmune hepatitisQ81230534
Autoimmune hepatitisQ82936688
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjectautoimmune hepatitisQ786844
P304page(s)281-285
P577publication date2016-06-01
P1433published inClinical and molecular hepatologyQ26853927
P1476titleMycophenolate mofetil as an alternative treatment for autoimmune hepatitis
P478volume22

Reverse relations

cites work (P2860)
Q42358509Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments
Q55428911Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta-analysis.
Q44247097Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba
Q90379391Human Cytomegalovirus Upregulates Expression of HCLS1 Resulting in Increased Cell Motility and Transendothelial Migration during Latency